Researchers investigated the behavioral and pharmacological effects of self-medicative plants in the diets of Budongo chimpanzees.
ARCH, one of life sciences’ premier investors, eyes $3B for 13th fund
ARCH Venture Partners plans to raise $3 billion for its 13th fund, per a new SEC filing from this week. The Chicago-based venture capital firm